Digital Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global Digital Vaccine Market is projected to witness impressive growth during the forecast period. Global digital vaccine market stood at USD 1534.07 million in 2022 and is expected to register a CAGR of 10.66% and reach USD 2779.10 million by 2028. The goal of Digital Vaccine is to change behavior patterns and enhance both mental and physical health by employing neurocognitive training and nudging tactics. A digital vaccination is a tool that trains the brain and encourages good habits using a variety of digital technologies, such as virtual reality, smartphone apps, and artificial intelligence. Moreover, digital vaccines are cutting-edge technologies that can aid individuals in enhancing their mental health and encouraging positive behavior. They are affordable, simple to use, and adaptable to different demands. Also, they have the ability to help where it is most needed and reach a huge audience. Digital vaccinations hold great promise for enhancing mental health and encouraging good conduct in people. These vaccinations have the ability to assist people in forming healthier behaviors and leading better, more meaningful lives by combining neurocognitive training and nudging strategies. The potential for digital vaccines to promote positive change is enormous and exciting as digital technologies continue to develop.

Digital vaccines have undergone a revolution as a result of the booming healthcare IT market and the development of cutting-edge ideas like the Internet of Things (IoT), wearable technology, metaverse platforms, and augmented reality (AR/VR). These innovations are allowing for much more frequent behavioral interventions to treat a wide range of diseases and phobias. For instance, the National Center for Telehealth and Technology (T2) of the US Department of Defense has created a computer application Virtual PTSD Experience which is based on the internationally populated virtual world called second life. In this virtual reality video game, military soldiers can create a virtual avatar to play through scenarios that are realistic and help with mental health issues. Further, in order to increase the effectiveness and precision of needle-free vaccines in treating patients for various diseases or phobias, artificial intelligence and machine learning are being employed more and more in digital vaccine management systems. Moreover, AI and machine learning can aid in the creation of video games and mobile applications that encourage youngsters to adopt healthy eating habits and active lifestyles. Avatars powered by AI are also the foundation of the first digital vaccine to be granted a US patent.

Growing Prevalence of Diseases

Noncommunicable diseases (NCDs) impact people from all age groups, geographical areas, and nations. Although these illnesses are frequently linked to older age groups, statistics show that 17 million deaths from Non-communicable diseases (NCDs) happen before the age of 70. According to estimates, 86% of these early fatalities take place in low- and middle-income nations, owing to a lack of awareness and availability of digital technologies. As per World Health Organization (WHO), noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally which is expected to boost the demand of digital vaccines throughout the forecast period.

Additionally, children, adults, and seniors are susceptible to the risk factors for Non-communicable diseases (NCDs), including poor diets, inactivity, exposure to tobacco smoke, and problematic alcohol use which in turn is driving the demand for digital vaccines to adopt healthy eating habits or lifestyle among individuals. Further, the prevalence of various diseases such as diabetes, cancer, and cardiovascular diseases, among others, which can be managed by adopting a healthy eating habit or lifestyle, is expected to increase the demand for products such as digital vaccines. For instance, cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes). Hence, with the help of tablets, smartphones, and other such devices, Digital Vaccine hopes to deliver healthcare. It aids in reducing disease risk, symptom severity, and hospitalization of patients with any diseases.

Focus on Personalized Medicine

One of the most promising methods for combating diseases especially in case of the diseases lacking any kind of potential treatment, is precision medicine, often known as personalized medicine. People, families, and entire civilizations suffer greatly as a result of cancer, neurological illnesses, and unusual genetic abnormalities. Due to greater patient response and the maximum safety margin to assure better patient care, personalized medicines have recently grown in favor among healthcare professionals. The potential for improved healthcare, even at a cheaper cost, is shown by personalized therapeutics. The patient can benefit from an early diagnosis, risk management, and the best possible care. Moreover, an increasing tendency that aimed to provide patients with personalized care gave rise to personalized medicine which led the growth of the digital vaccine market. Further, the use of digital biomarkers to define more exact outcome measures and clinical research objectives is becoming more and more important. They can involve voice-recorded mood and disease progression, cognitive exams performed as games on tablets, and actigraphy. Hence, rising awareness and focus on personalized medicines drive the growth of digital vaccines throughout the forecast period.

Increase in Clinical Trials and Patents of Digital Vaccine

The demand for digital vaccines has grown dramatically over time as a result of rising knowledge about them and their advantages in the treatment of various diseases and phobias. In turn, this has considerably boosted the amount of research and development being done on digital vaccinations, which has raised the number of clinical studies being conducted around the world. Also, many people are keen to engage in clinical studies for digital vaccinations, which will support market expansion through 2028. Further, rising patents of digital vaccines are expected to support the growth of the market. For instance, Vydiant Inc. filed a patent on 25 March 2022; titled “A Digital Vaccine System, Method and Device”. A collection of tuples that affect a pathogen's risk of causing infection which is saved on a non-transitory computer-readable device known as a pathogen knowledge base. The Digital Vaccine System's assessment of a pathogen risk and delivery of pathogen risk recommendations to one or more users, is based on an infection risk value that indicates the probability of a user having the pathogen parameter. Moreover, Haddad Alias also filed the patent for cybercriminal activity of a digital vaccine app on 19 September 2017 and got published on 19 October 2021, titled “Enhanced Computer Objects Security”. Hence, increasing clinical trials and patents on digital vaccines is fueling market expansion and awareness among individuals.

Data Privacy and Security Concerns to Hamper the Growth of the Market

Confidentiality of patient data is stored in digital vaccine management systems, so protecting the privacy and security of this information is of utmost importance. Hacking, data breaches, and unauthorized access to this sensitive information are worries. This is a significant worry that prevents individuals from adopting many digital vaccine solutions. Furthermore, the lack of consistent internet and electronic device connectivity makes it challenging to apply digital vaccine management systems efficiently in many parts of the world. Also, a lack of knowledge about cutting-edge solutions like digital vaccinations among the populace, particularly in developing and emerging nations, may hinder the expansion of the global market for digital vaccines.


Download Free Sample Report

Market Segmentation

The Global Digital Vaccine Market is segmented based on device type and application. Based on device type, the market is divided into smartphones, tablets, and others. Based on application, the market is categorized into Diabetes, Infectious Diseases, Cardiovascular Diseases, and Others.

Market players

FriendsLearn, Inc., Klein Buendel, Inc, Evidation Health, Inc., Atos SE, oVRcome.

Attribute

Details

Market Size in 2022

USD 1534.07 Million

Market Size in 2028

USD 2779.10 Million

Growth Rate

10.66%

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Device Type

By Application

Regional scope

Asia Pacific; North America; Europe; Middle East & Africa; South America;

Country scope

India; Australia; China; Japan; Thailand; United States; Canada; Mexico; Franc; United Kingdom; Italy; Denmark, Germany; Saudi Africa; Nigeria; UAE; Saudi Arabia; Argentina; Brazil; Colombia

Key companies profiled

FriendsLearn, Inc., Klein Buendel, Inc, Evidation Health, Inc., Atos SE, oVRcome

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Digital Vaccine Market, By Device Type:
    • Smartphones
    • Tablets
    • Others
  • Global Digital Vaccine Market, By Application:
    • Diabetes
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others
  •  Global Digital Vaccine Market, By Region:
    • Asia-Pacific
      • India
      • Australia
      • China
      • Japan
      • Thailand
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • United Kingdom
      • Italy
      • Denmark
      • Germany
    • Middle East & Africa

§  Saudi Africa

§  Nigeria

§  UAE

§  Saudi Arabia

    • South America
      • Argentina
      • Brazil

§  Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Digital Vaccine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Impact of COVID-19 on Global Digital Vaccine Market

5.    Clinical Trial Analysis

6.    Patent Analysis

7.    Voice of Customer

8.    Global Digital Vaccine Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Device Type (Smartphones, Tablets, Others)

8.2.2.     By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

8.2.3.     By Region

8.2.4.     By Company (2022)

9.    Asia-Pacific Digital Vaccine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Device Type (Smartphones, Tablets, Others)

9.2.2.     By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

9.2.3.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Digital Vaccine Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Device Type

9.3.1.2.2.             By Application

9.3.2.     Australia Digital Vaccine Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Device Type

9.3.2.2.2.             By Application

9.3.3.     China Digital Vaccine Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Device Type

9.3.3.2.2.             By Application

9.3.4.     Japan Digital Vaccine Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Device Type

9.3.4.2.2.             By Application

9.3.5.     Thailand Digital Vaccine Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Device Type

9.3.5.2.2.             By Application

10.  North America Digital Vaccine Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Device Type (Smartphones, Tablets, Others)

10.2.2.  By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

10.2.3.  By Country

10.3.              North America: Country Analysis

10.3.1.  United States Digital Vaccine Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Device Type

10.3.1.2.2.           By Application

10.3.2.  Canada Digital Vaccine Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Device Type

10.3.2.2.2.           By Application

10.3.3.  Mexico Digital Vaccine Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Device Type

10.3.3.2.2.           By Application

11.  Europe Digital Vaccine Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Device Type (Smartphones, Tablets, Others)

11.2.2.  By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

11.2.3.  By Country

11.3.              Europe: Country Analysis

11.3.1.  France Digital Vaccine Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Device Type

11.3.1.2.2.           By Application

11.3.2.  United Kingdom Digital Vaccine Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Device Type

11.3.2.2.2.           By Application

11.3.3.  Italy Digital Vaccine Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Device Type

11.3.3.2.2.           By Application

11.3.4.  Denmark Digital Vaccine Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Device Type

11.3.4.2.2.           By Application

11.3.5.  Germany Digital Vaccine Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Device Type

11.3.5.2.2.           By Application

12.  Middle East and Africa Digital Vaccine Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Device Type (Smartphones, Tablets, Others)

12.2.2.  By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

12.2.3.  By Country

12.3.              MEA: Country Analysis

12.3.1.  South Africa Digital Vaccine Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Device Type

12.3.1.2.2.           By Application

12.3.2.  Nigeria Digital Vaccine Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Device Type

12.3.2.2.2.           By Application

12.3.3.  UAE Digital Vaccine Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Device Type

12.3.3.2.2.           By Application

12.3.4.  Saudi Arabia Digital Vaccine Market Outlook

12.3.4.1.      Market Size & Forecast

12.3.4.1.1.           By Value

12.3.4.2.      Market Share & Forecast

12.3.4.2.1.           By Device Type

12.3.4.2.2.           By Application

13.  South America Digital Vaccine Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Device Type (Smartphones, Tablets, Others)

13.2.2.  By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)

13.2.3.  By Country

13.3.              South America: Country Analysis

13.3.1.  Argentina Digital Vaccine Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Device Type

13.3.1.2.2.           By Application

13.3.2.  Brazil Digital Vaccine Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Device Type

13.3.2.2.2.           By Application

13.3.3.  Colombia Digital Vaccine Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Device Type

13.3.3.2.2.           By Application

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Market Trends & Developments

15.1.              Product Launches

15.2.              Mergers & Acquisitions

15.3.              Technological Advancements

16.  Global Digital Vaccine Market: SWOT Analysis

17.  Competitive Landscape

17.1.              FriendsLearn, Inc.

17.2.              Klein Buendel, Inc

17.3.              Evidation Health, Inc.

17.4.              Atos SE

17.5.              oVRcome

18.  Strategic Recommendation

19.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The global digital vaccine market is expected to grow at a CAGR of 10.66% and reach USD2779.10 million due to increasing prevalence of lifestyle related disorders such as hypertension, diabetes, among others, which require continuous management of diet and lifestyle.

down-arrow

FriendsLearn, Inc., Klein Buendel, Inc, Evidation Health, Inc., Atos SE, oVRcome are the major market players operating in the global Digital Vaccine Market.

down-arrow

Based on application, the market is divided into Diabetes, Infectious Diseases, Cardiovascular Diseases, Others. The diabetes segment captured a market share of 42.55% in 2022 and is expected to dominate throughout the forecast period. This is due to rising sedentary lifestyle patterns and high consumption of junk food.

down-arrow

Asia Pacific dominated the Global Digital Vaccine Market with a market share of 37.56% in 2022. This is on the account of growing awareness and rising digital vaccine market players in the region.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Digital Vaccines Market to grow at a CAGR of 10.66% and reach USD2779.10 million by 2028

Mar, 2023

Increasing clinical trials on digital vaccine and focus on personalized medicines are driving the growth of the market in the forecast period 2024-2028.

Why Choose Us